AllQuantitative Report
logoArgusMay 05, 2021

CARA: Lowering target price to $13.00

Symbols
CARA
Sector(s)
Healthcare
Rating
Current Price
$13.89
Price Target
$NaN
Earnings Estimate
Summary

Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus.

Subscribe to Yahoo Finance Plus Essential for full access
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
Try it Free